Elevated Cholesterol Reported in Blood Tests on Children
|
By LabMedica International staff writers Posted on 28 Jul 2010 |
The concentration of low-density lipoprotein (LDL) in the blood is a guide to the health of the individual. Increased LDL cholesterol is indicative of type 2 diabetes and early heart attacks.
The normal value of LDL for children ages 2-19 years is under 130 mg/dL. Serum concentrations of total cholesterol and triglycerides are determined using enzymatic procedures. Children are seldom checked for their cholesterol levels as screening them has until recently not been considered a priority.
In a study, 20,266 fifth-grade children, had blood taken and a lipid panel analysis was performed. The panel included total cholesterol, triglycerides, and LDL and, very-low density lipoprotein (VLDL) serum levels (Abbott, North Chicago, IL, USA). The LDL and VLDL concentration were measured after heparin–calcium precipitation and determined by densitometric (electrophoretic) ratio and cholesterol content of the two lipoproteins.
The study found that among the 11-year-olds who met current cholesterol screening guidelines, 8.3% had LDL cholesterol levels of 130 mg/dL or higher, and 1.2% had LDL cholesterol levels of 160 mg/dL or higher. Among the 11-year-olds who would not have been screened under current guidelines, 9.5% had LDL cholesterol levels of 130 mg/dL or higher and 1.7% had LDL cholesterol levels of 160 mg/dL or higher.
More than 70% of the 20,266 children who were screened would have qualified for routine cholesterol screening, according to current U.S. National Cholesterol Education Program (NCEP; Bethesda, MD, USA) guidelines. But even more surprising was how many children had high cholesterol even though they would not have qualified for routine screening. The study was performed at the West Virginia University, (West Virginia University, Morgantown, WV, USA).
William Neal, MD, professor of pediatrics at West Virginia University, said, "A lot of parents told us they did not even know children had cholesterol, let alone high cholesterol. Just as many children who would not have been screened ended up with severely high cholesterol levels as in the group that did qualify for screening based on family history.” One in three children with dangerously high cholesterol is missed by current screening recommendations. The study was published in July 2010 in Pediatrics.
Related Links:
Abbott
U.S. National Cholesterol Education Program
West Virginia University
The normal value of LDL for children ages 2-19 years is under 130 mg/dL. Serum concentrations of total cholesterol and triglycerides are determined using enzymatic procedures. Children are seldom checked for their cholesterol levels as screening them has until recently not been considered a priority.
In a study, 20,266 fifth-grade children, had blood taken and a lipid panel analysis was performed. The panel included total cholesterol, triglycerides, and LDL and, very-low density lipoprotein (VLDL) serum levels (Abbott, North Chicago, IL, USA). The LDL and VLDL concentration were measured after heparin–calcium precipitation and determined by densitometric (electrophoretic) ratio and cholesterol content of the two lipoproteins.
The study found that among the 11-year-olds who met current cholesterol screening guidelines, 8.3% had LDL cholesterol levels of 130 mg/dL or higher, and 1.2% had LDL cholesterol levels of 160 mg/dL or higher. Among the 11-year-olds who would not have been screened under current guidelines, 9.5% had LDL cholesterol levels of 130 mg/dL or higher and 1.7% had LDL cholesterol levels of 160 mg/dL or higher.
More than 70% of the 20,266 children who were screened would have qualified for routine cholesterol screening, according to current U.S. National Cholesterol Education Program (NCEP; Bethesda, MD, USA) guidelines. But even more surprising was how many children had high cholesterol even though they would not have qualified for routine screening. The study was performed at the West Virginia University, (West Virginia University, Morgantown, WV, USA).
William Neal, MD, professor of pediatrics at West Virginia University, said, "A lot of parents told us they did not even know children had cholesterol, let alone high cholesterol. Just as many children who would not have been screened ended up with severely high cholesterol levels as in the group that did qualify for screening based on family history.” One in three children with dangerously high cholesterol is missed by current screening recommendations. The study was published in July 2010 in Pediatrics.
Related Links:
Abbott
U.S. National Cholesterol Education Program
West Virginia University
Latest Clinical Chem. News
- Urinary Biomarker Assay Predicts Kidney Disease Progression Beyond Standard Measures
- Saliva-Based Test Detects Biochemical Signs of Sleep Loss
- Simple Dual-Tau Blood Test Detects and Stages Alzheimer’s Disease
- Alzheimer’s Blood Biomarkers Linked to Early Cognitive Differences Before Dementia
- Urine-Based Test Shows Promise for Autism Screening in Children
- Blood-Based Sensor Detects Early Signs of Alzheimer’s and Parkinson’s
- Liquid Biopsy Biomarkers May Improve Childhood Epilepsy Diagnosis
- Urine-Based Alzheimer’s Test Receives FDA Breakthrough Device Designation
- Fluid Biomarker Improves Diagnosis and Monitoring of Primary CNS Lymphoma
- New CA19-9 Cutoff Value Helps Identify High-Risk Pancreatic Cancer Patients
- Blood-Based Biomarkers Show Promise for Psychosis Risk Prediction
- International Experts Recommend Ending Routine 'Corrected' Calcium Reporting
- Long-Term Data Show PSA Screening Modestly Reduces Prostate Cancer Deaths
- Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively
- FDA-Cleared Assay Enables Comprehensive Automated Testosterone Testing
- CE-Marked Blood Biomarker Test Advances Automated Alzheimer’s Diagnostics
Channels
Molecular Diagnostics
view channel
Blood-Based RNA Test May Predict Chemotherapy Sensitivity in Lung Cancer
Lung cancer care increasingly relies on biomarker-guided patient stratification, but tissue biopsy can be impractical and treatment selection remains difficult for many patients. Blood-based assays that... Read more
Blood Test Predicts Immunotherapy Response in Head and Neck Cancer
Head and neck squamous cell carcinoma affects hundreds of thousands of people worldwide each year, yet response rates to immunotherapy remain low. Clinicians lack reliable, minimally invasive tools to... Read moreHematology
view channel
Next-Generation Hematology Platform Streamlines High-Complexity Lab Workflows
Sysmex America (Chicago, IL, USA) has introduced the next generation XR-Series, centered on the XR-10 Automated Hematology Module for high-complexity laboratories. The platform builds on the widely used... Read more
Blood Eosinophil Count May Predict Cancer Immunotherapy Response and Toxicity
Immune checkpoint inhibitors have improved outcomes across many cancers, yet only a subset of patients derive durable benefit and biomarkers to guide treatment remain limited. Eosinophils, best known for... Read moreImmunology
view channelAptamer-Based Biosensor Enables Mutation-Resilient SARS-CoV-2 Detection
Rapid evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can undermine existing molecular diagnostics, especially when assays target small viral components. Double-antibody sandwich... Read more
Study Points to Autoimmune Pathway Behind Long COVID Symptoms
Long COVID leaves many SARS-CoV-2 survivors with persistent fatigue, cognitive issues, palpitations, and musculoskeletal pain for months or years. Estimates cited in new research suggest 4%–20% of infected... Read more
Metabolic Biomarker Distinguishes Latent from Active Tuberculosis and Tracks Treatment Response
Tuberculosis (TB) remains the world’s leading infectious killer, with 10.8 million cases and 1.25 million deaths recorded globally in 2023. Yet many infected individuals never develop active disease, underscoring... Read moreMicrobiology
view channel
New Culture Medium Speeds C. difficile Resistance Detection and Reduces Costs
Clostridioides difficile infections remain a persistent threat in hospitals and communities, affecting about 500,000 people in the United States each year. Severe cases can be fatal within 30 days of diagnosis,... Read more
Automated Blood Culture System Speeds Detection of Bloodstream Infections
Bloodstream infections and sepsis require rapid laboratory detection to guide targeted antimicrobial therapy and reduce mortality. Conventional blood culture workflows can delay actionable results by critical... Read morePathology
view channel
AI Pathology Tool Predicts Meningioma Recurrence from Routine Slides
Meningiomas are the most common primary brain tumors in adults, yet their course ranges from indolent to highly recurrent disease. Estimating an individual patient’s recurrence risk often requires advanced... Read more
3D Spatial Multi-Omics Maps Intra-Tumor Diversity in Colorectal Cancer
Colorectal cancer remains a leading cause of cancer death, and clinical decision-making is complicated by marked intra-tumor heterogeneity. Conventional bulk sequencing averages molecular signals across... Read moreTechnology
view channel
AI Platform Links Biomarker Results to Cancer Clinical Trials and Guidelines
Oncology teams must manage growing volumes of genomic data, rapidly evolving clinical trial options, and frequently updated care guidelines, all within tight clinic schedules. Translating complex tumor... Read more
Agentic AI Platform Supports Genomic Decision-Making in Oncology
Oncology care teams increasingly face the challenge of managing complex molecular diagnostics, evolving treatment options, and extensive electronic health record documentation. Translating multimodal data... Read moreIndustry
view channel
Genetic Testing Program Expands Detection of Alpha-1 Antitrypsin Deficiency
Alpha-1 Antitrypsin Deficiency (AATD) is a progressive genetic condition, the leading known genetic risk factor for chronic obstructive pulmonary disease (COPD), and a cause of liver disease in both children... Read more








